An Open-label, Fixed-sequence, Phase 1 Study of the Effect of CYP3A4 Inhibition by Itraconazole on the Pharmacokinetics of BIIB074 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Raxatrigine (Primary) ; Itraconazole
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Biogen
- 01 Sep 2017 Results published in the Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology.
- 07 Jun 2016 Status changed from recruiting to completed.
- 18 Apr 2016 Status changed from not yet recruiting to recruiting.